Pacific Biosciences
PACB
PACB
221 hedge funds and large institutions have $265M invested in Pacific Biosciences in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 57 increasing their positions, 73 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
19.2% less ownership
Funds ownership: 94.77% → 75.57% (-19%)
22% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 73
44% less capital invested
Capital invested by funds: $475M → $265M (-$210M)
Holders
221
Holding in Top 10
2
Calls
$4.29M
Puts
$1.73M
Top Buyers
| 1 | +$1.22M | |
| 2 | +$1.18M | |
| 3 | +$942K | |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$600K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$576K |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$5.12M | |
| 3 | -$3.56M | |
| 4 |
Goldman Sachs
New York
|
-$3.46M |
| 5 |
Morgan Stanley
New York
|
-$2.69M |
